$20m cash in the upcoming quarterly would be a great result.
It's thoroughly believable that deals are contingent on an FDA go ahead, if any deal happens the validation will send the SP soaring imo.
$20m cash in the upcoming quarterly would be a great result....
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.015(7.50%) |
Mkt cap ! $75.30M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.5¢ | $101.7K | 478.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 109430 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 66001 | 5 |
View Market Depth
| Last trade - 14.52pm 03/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |